Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
O'Reilly Automotive
ORLY
|
+$450M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$321M |
| 3 |
Costco
COST
|
+$263M |
| 4 |
Ferrari
RACE
|
+$253M |
| 5 |
GE HealthCare
GEHC
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$998M |
| 2 |
Microsoft
MSFT
|
+$581M |
| 3 |
Apple
AAPL
|
+$553M |
| 4 |
Bank of America
BAC
|
+$301M |
| 5 |
UnitedHealth
UNH
|
+$285M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.47% |
| 2 | Healthcare | 13.56% |
| 3 | Financials | 11.46% |
| 4 | Consumer Discretionary | 9.53% |
| 5 | Industrials | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3376
First Bank
FRBA
$471M
| $585K | ﹤0.01% |
57,926
-472
| -0.8% | -$6.08K |
|
3377
Lands' End
LE
$391M
| $585K | ﹤0.01% |
60,190
-2,310
| -4% | -$19.3K |
|
3378
PMV Pharmaceuticals
PMVP
$67.2M
| $584K | ﹤0.01% |
122,520
-279
| -0.2% | -$1.96K |
|
3379
Blend Labs
BLND
$331M
| $582K | ﹤0.01% |
584,005
-3,101,754
| -84% | -$4.75M |
|
3380
Noodles & Co
NDLS
$98M
| $580K | ﹤0.01% |
14,958
+941
| +7% | +$43K |
|
3381
iShares Core S&P US Growth ETF
IUSG
$34B
| $579K | ﹤0.01% |
6,522
-404,384
| -98% | -$34.4M |
|
3382
InterContinental Hotels
IHG
$23.9B
| $578K | ﹤0.01% |
8,685
+98
| +1% | +$6.63K |
|
|
SRTA
3383
Strata Critical Medical Inc
SRTA
$533M
| $578K | ﹤0.01% |
170,860
-2,639
| -2% | -$10.8K |
|
|
RSVR
3384
Reservoir Media
RSVR
$646M
| $577K | ﹤0.01% |
88,501
-7,417
| -8% | -$49.2K |
|
3385
iShares North American Natural Resources ETF
IGE
$781M
| $577K | ﹤0.01% |
14,719
+72
| +0.5% | +$2.9K |
|
3386
Adicet Bio
ACET
$77.3M
| $576K | ﹤0.01% |
6,253
+22
| +0.4% | +$2.76K |
|
3387
Saga Communications
SGA
$64.6M
| $576K | ﹤0.01% |
25,892
+181
| +0.7% | +$4.33K |
|
|
BINI
3388
DELISTED
Bollinger Innovations
BINI
| – | – |
0
| – | – |
|
|
AKYA
3389
DELISTED
Akoya BioSciences
AKYA
| $574K | ﹤0.01% |
70,229
-1,333
| -2% | -$13.9K |
|
3390
Smith & Nephew
SNN
$12.6B
| $570K | ﹤0.01% |
20,413
+722
| +4% | +$20.5K |
|
3391
The RealReal
REAL
$1.36B
| $568K | ﹤0.01% |
451,073
-1,944
| -0.4% | -$2.82K |
|
3392
Meridian
MRBK
$240M
| $566K | ﹤0.01% |
44,930
+248
| +0.6% | +$3.78K |
|
3393
Harvard Bioscience
HBIO
$28.1M
| $565K | ﹤0.01% |
13,455
| – | – |
|
3394
ProShares Short S&P500
SH
$839M
| $564K | ﹤0.01% |
9,404
-250
| -3% | -$15.4K |
|
|
KZR
3395
DELISTED
Kezar Life Sciences
KZR
| $564K | ﹤0.01% |
18,016
-204
| -1% | -$11.8K |
|
|
YMAB
3396
DELISTED
Y-mAbs Therapeutics
YMAB
| $564K | ﹤0.01% |
112,531
-809
| -0.7% | -$3.3K |
|
3397
Canterbury Park Holding Corp
CPHC
$80.8M
| $563K | ﹤0.01% |
22,867
+183
| +0.8% | +$4.85K |
|
3398
Forum Energy Technologies
FET
$932M
| $561K | ﹤0.01% |
22,071
| – | – |
|
|
JBIO
3399
Jade Biosciences
JBIO
$1.48B
| $561K | ﹤0.01% |
794
-9
| -1% | -$7.46K |
|
3400
NextDecade
NEXT
$1.8B
| $560K | ﹤0.01% |
112,752
-11,289
| -9% | -$65.6K |
|
Similar funds
Bank of New York Mellon's Q1 2023 Portfolio in Review
As of Q1 2023, Bank of New York Mellon held 4,561 positions worth $457B, up 4.4% from $438B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Bank of New York Mellon's Q1 2023 filing shows 99 new, 1,204 increased, 2,632 reduced and 170 closed positions. Its largest new stake was GE HealthCare: 3,007,926 shares worth $247M. The largest sale was Johnson & Johnson, an estimated $998M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q1 2023 buy was GE HealthCare: 3,007,926 shares worth $247M.
- Bank of New York Mellon added most to O'Reilly Automotive in Q1 2023, an estimated $450M increase.
- Bank of New York Mellon's biggest Q1 2023 reduction was Johnson & Johnson, cutting an estimated $998M.
- Bank of New York Mellon fully exited STORE Capital Corporation in Q1 2023, selling an estimated $109M.
- Bank of New York Mellon's ten largest holdings make up 19% of its $457B portfolio in Q1 2023.
- Bank of New York Mellon opened 99 new positions and closed 170 in Q1 2023.
- Bank of New York Mellon's portfolio value rose 4.4% quarter-over-quarter to $457B.
Based on Bank of New York Mellon's 13F filing for Q1 2023, filed 9 May 2023.